NASDAQ:DRAD - Digirad Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.61 -0.04 (-6.15 %) (As of 12/11/2018 04:00 PM ET)Previous Close$0.65Today's Range$0.61 - $0.6752-Week Range$0.61 - $3.05Volume217,100 shsAverage Volume84,264 shsMarket Capitalization$14.77 millionP/E RatioN/ADividend Yield30.14%Beta2.03 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Digirad Corporation provides healthcare solutions in the United States. It operates through Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging segments. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services, as well as offers remote cardiac event monitoring services. The Mobile Healthcare segment offers contract diagnostic imaging services, including computerized tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. The Diagnostic Imaging segment develops and sells gamma camera imaging systems, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance services. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia. Receive DRAD News and Ratings via Email Sign-up to receive the latest news and ratings for DRAD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DRAD Previous Symbol CUSIPN/A Webwww.digirad.com Phone858-726-1600 Debt Debt-to-Equity Ratio0.50 Current Ratio1.83 Quick Ratio1.35 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$118.34 million Price / Sales0.10 Cash Flow$0.5865 per share Price / Cash Flow1.04 Book Value$1.39 per share Price / Book0.44 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-35,730,000.00 Net Margins-18.00% Return on Equity-15.04% Return on Assets-7.26% Miscellaneous Employees515 Outstanding Shares20,230,000Market Cap$14.77 million OptionableOptionable Digirad (NASDAQ:DRAD) Frequently Asked Questions What is Digirad's stock symbol? Digirad trades on the NASDAQ under the ticker symbol "DRAD." How often does Digirad pay dividends? What is the dividend yield for Digirad? Digirad announced a quarterly dividend on Friday, August 3rd. Shareholders of record on Thursday, August 16th will be paid a dividend of $0.055 per share on Thursday, August 30th. This represents a $0.22 annualized dividend and a yield of 36.07%. The ex-dividend date is Wednesday, August 15th. View Digirad's Dividend History. How were Digirad's earnings last quarter? Digirad Co. (NASDAQ:DRAD) issued its quarterly earnings data on Friday, November, 2nd. The medical equipment provider reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.02) by $0.01. The medical equipment provider had revenue of $25.71 million for the quarter. Digirad had a negative return on equity of 15.04% and a negative net margin of 18.00%. View Digirad's Earnings History. When is Digirad's next earnings date? Digirad is scheduled to release their next quarterly earnings announcement on Friday, February 22nd 2019. View Earnings Estimates for Digirad. What guidance has Digirad issued on next quarter's earnings? Digirad issued an update on its FY 2018 earnings guidance on Friday, November, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $100-105 million, compared to the consensus revenue estimate of $103.26 million. Has Digirad been receiving favorable news coverage? News coverage about DRAD stock has trended somewhat positive this week, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Digirad earned a daily sentiment score of 1.1 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future. Who are some of Digirad's key competitors? Some companies that are related to Digirad include IRIDEX (IRIX), Viveve Medical (VIVE), Soleno Therapeutics (SLNO), Precision Optics (PEYE), Nexeon Medsystems (NXNN), ENDRA Life Sciences (NDRA), Aradigm (ARDM), Non-Invasive Monitoring Systems (NIMU), Vaso (VASO), CHF Solutions (CHFS), Escalon Medical (ESMC), SpectraScience (SCIE), Trimedyne (TMED), Magna-Lab (MAGAA) and Reshape Lifesciences (RSLS). Who are Digirad's key executives? Digirad's management team includes the folowing people: Mr. Matthew Gabel Molchan, Pres, CEO, Interim CFO & Director (Age 51)Mr. Martin B. Shirley, Pres of Digirad Imaging Solutions (Age 56)Mr. Michael Debeauvernet, Gen. Mang. of Mobile Imaging (Age 57)Mr. David James Noble, Chief Operating Officer (Age 48)Mr. Bob Halbert, Sr. Director of Human Resource Who are Digirad's major shareholders? Digirad's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Heartland Advisors Inc. (2.49%) and Macquarie Group Ltd. (0.39%). Company insiders that own Digirad stock include Cannell Capital Llc, David James Noble, Jeffrey E Eberwein, Jeffry R Keyes, Matthew G Molchan, Michael A Cunnion and Virgil Lott. View Institutional Ownership Trends for Digirad. Which major investors are selling Digirad stock? DRAD stock was sold by a variety of institutional investors in the last quarter, including Heartland Advisors Inc. and Macquarie Group Ltd.. Company insiders that have sold Digirad company stock in the last year include Cannell Capital Llc and Virgil Lott. View Insider Buying and Selling for Digirad. How do I buy shares of Digirad? Shares of DRAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Digirad's stock price today? One share of DRAD stock can currently be purchased for approximately $0.61. How big of a company is Digirad? Digirad has a market capitalization of $14.77 million and generates $118.34 million in revenue each year. Digirad employs 515 workers across the globe. What is Digirad's official website? The official website for Digirad is http://www.digirad.com. How can I contact Digirad? Digirad's mailing address is 1048 INDUSTRIAL COURT, SUWANEE GA, 30024. The medical equipment provider can be reached via phone at 858-726-1600 or via email at [email protected] MarketBeat Community Rating for Digirad (NASDAQ DRAD)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 250 (Vote Outperform)Underperform Votes: 191 (Vote Underperform)Total Votes: 441MarketBeat's community ratings are surveys of what our community members think about Digirad and other stocks. Vote "Outperform" if you believe DRAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DRAD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/11/2018 by MarketBeat.com StaffFeatured Article: What does cost of debt say about a company’s financial health?